Muhamed Baljevic

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Venous Thromboembolism

Multiple Myeloma

Inferior Vena Cava

Top Venues

Bone marrow transplantation

Blood cancer journal

Antimicrobial stewardship & healthcare epidemiology : ASHE

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Muhamed Baljevic, Salyka Sengsayadeth
Relapsed systemic light chain amyloidosis - in search of a higher bar. Bone marrow transplantation (2024)
Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era. Blood cancer journal 14 (1) (2024)
Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era. Blood cancer journal 14 (1) (2024)
Muhamed Baljevic, Salyka Sengsayadeth
Relapsed systemic light chain amyloidosis - in search of a higher bar. Bone marrow transplantation 59 (4) (2024)
Muhamed Baljevic, Salyka Sengsayadeth
Relapsed systemic light chain amyloidosis - in search of a higher bar. Bone marrow transplantation 59 (4) (2024)
Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
Long term responders in frontline multiple myeloma-exception vs expectation of the modern era. Blood cancer journal 14 (1) (2024)
Chelsea A Gorsline, Ryan M Miller, Laura J Bobbitt, Gowri Satyanarayana, Muhamed Baljevic, Milner B O Staub
Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Chelsea A Gorsline, Ryan M Miller, Laura J Bobbitt, Gowri Satyanarayana, Muhamed Baljevic, Milner B O Staub
Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic, Anita D Souza, Peter G Pappas, Jesus G Berdeja, Natalie Callander, Luciano José Megale Costa
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma. British journal of haematology (2023)
Chelsea A Gorsline, Ryan M Miller, Laura J Bobbitt, Gowri Satyanarayana, Muhamed Baljevic, Milner B O Staub
Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Muhamed Baljevic, Douglas W Sborov
Understanding risks and refining strategies for thromboembolism prophylaxis in hematopoietic stem cell transplant recipients. Bone marrow transplantation (2023)
Muhamed Baljevic, Cristina Gasparetto, Gary J Schiller, Sascha A Tuchman, Natalie S Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J Bahlis, Darrell White, Christine I Chen, Heather J Sutherland, Sumit Madan, Richard LeBlanc, Michael Sebag, Christopher P Venner, William I Bensinger, Noa Biran, Andrew DeCastro, Dane R Van Domelen, Chris Zhang, Jatin J Shah, Sharon Shacham, Michael G Kauffman, Ohad S Bentur, Brea Lipe
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment. EJHaem 3 (4) (2022)
Jorge J Castillo, Natalie S Callander, Muhamed Baljevic, Douglas W Sborov, Shaji K Kumar
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. American journal of hematology 96 (7) (2021)
Samia Asif, Meghana Kesireddy, Scott A Koepsell, Marco A Gonzalez-Castellon, Krishna Gundabolu, Muhamed Baljevic
Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject. The Neurohospitalist 12 (2) (2021)
Muhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani, Yan Heather Lin, Claudia Morales de Partovi, Zuzana Berkova, Behrang Amini, Sheeba K Thomas, Jatin J Shah, Donna M Weber, Min Fu, Charles S Cleeland, Xin Shelley Wang, Christine M Stellrecht, Richard E Davis, Varsha Gandhi, Robert Z Orlowski
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma. Annals of hematology 96 (6) (2017)